Utkan G, Buyukcelik A, Demir O, Sanli H, Pamir A
Department of Medical Oncology, Ankara University School of Medicine, Ibni Sina Hospital, 06100 Sihhiye, Ankara, Turkey.
Acta Med Austriaca. 2003;30(5):138-41.
Post-transfusion graft-versus-host disease (PT-GVHD) is seldom, but it has a high mortality rate, exceeding 90 percent. There is no standard treatment for PT-GVHD and irradiation of blood and its components before transfusion is broadly accepted for the prevention of PT-GVHD. In this report we present a case (a 17-year-old female) of PT GVHD, who died in spite of the use of all available therapeutic options.
输血后移植物抗宿主病(PT-GVHD)虽罕见,但死亡率很高,超过90%。目前尚无针对PT-GVHD的标准治疗方法,输血前对血液及其成分进行辐照以预防PT-GVHD已被广泛接受。在本报告中,我们介绍了一例PT-GVHD病例(一名17岁女性),尽管采用了所有可用的治疗方法,患者仍不幸死亡。